TLR9 agonist and CD40 agonist immunostimulatory combinations
US7993659B2 · kind B2 · utility
58Cited by
0References
51Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 17, 2008 |
| Grant date | Aug 9, 2011 |
| Priority date | — |
| Expiry date | Apr 9, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides immunostimulatory combinations. Generally, the immunostimulatory combinations include a TLR agonist and a TNF/R agonist. Certain immunostimulatory combinations also may include an antigen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.